1. Home
  2. AZTR vs BDRX Comparison

AZTR vs BDRX Comparison

Compare AZTR & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • BDRX
  • Stock Information
  • Founded
  • AZTR 2014
  • BDRX 2000
  • Country
  • AZTR United States
  • BDRX United Kingdom
  • Employees
  • AZTR N/A
  • BDRX N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AZTR Health Care
  • BDRX Health Care
  • Exchange
  • AZTR Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • AZTR 4.0M
  • BDRX 3.4M
  • IPO Year
  • AZTR 2023
  • BDRX N/A
  • Fundamental
  • Price
  • AZTR $0.45
  • BDRX $3.80
  • Analyst Decision
  • AZTR
  • BDRX Strong Buy
  • Analyst Count
  • AZTR 0
  • BDRX 1
  • Target Price
  • AZTR N/A
  • BDRX $200.00
  • AVG Volume (30 Days)
  • AZTR 187.3K
  • BDRX 55.5K
  • Earning Date
  • AZTR 11-12-2024
  • BDRX 11-26-2024
  • Dividend Yield
  • AZTR N/A
  • BDRX N/A
  • EPS Growth
  • AZTR N/A
  • BDRX N/A
  • EPS
  • AZTR N/A
  • BDRX N/A
  • Revenue
  • AZTR $97,500.00
  • BDRX $104,895.00
  • Revenue This Year
  • AZTR $494.75
  • BDRX N/A
  • Revenue Next Year
  • AZTR N/A
  • BDRX N/A
  • P/E Ratio
  • AZTR N/A
  • BDRX N/A
  • Revenue Growth
  • AZTR N/A
  • BDRX N/A
  • 52 Week Low
  • AZTR $0.43
  • BDRX $3.51
  • 52 Week High
  • AZTR $68.40
  • BDRX $220.25
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 33.29
  • BDRX 29.07
  • Support Level
  • AZTR $0.43
  • BDRX $4.70
  • Resistance Level
  • AZTR $0.60
  • BDRX $5.58
  • Average True Range (ATR)
  • AZTR 0.05
  • BDRX 0.48
  • MACD
  • AZTR -0.00
  • BDRX -0.08
  • Stochastic Oscillator
  • AZTR 8.93
  • BDRX 9.03

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Share on Social Networks: